So while diet and supplements may support normal GLP-1 signaling, they dont replicate the sustained effect of medication
The Therapeutic Goods Administration's (TGA) warning covers the following glucagon-like peptide-1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and obesity: Semaglutide, sold as Ozempic, Wegovy Tirzepatide, sold as Mounjaro Dulaglutide, sold as Trulicity Liraglutide, sold as Saxenda The TGA said the products had the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION)
As a mitochondrial-derived peptide, it behaves as a signaling molecule that communicates metabolic information from your mitochondria to the rest of your body
In fact, many of CJC-1295s purported benefits are based on animal studies
Metabolic Health Enhancement: Beyond weight, it supports healthier blood pressure and blood sugar, critical for overall reproductive health, especially for those wanting to lose weight before getting pregnant
Available online at: (Accessed October 17, 2025)